Stiefel Laboratories
2023–2024 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2023–2024 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Latest matching employer records · memo entries excluded from net amount
Read from indexed records .
Loading 10 contributions with dates…
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under Stiefel Laboratories.
These totals and connections use all matching indexed employer records, keeping the latest version within that employer group and excluding memo entries from net amounts. Amendments that change the reported employer may affect this grouping. No profile rebuild is required.
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for Stiefel Laboratories. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported name and ZIP groups; not verified unique people or cross-address identity matches · 10 per page
Showing 1–1 of 1 · largest absolute amount first
Reported name + ZIP cluster; not a verified identity merge · KITTY HAWK · NC · 27949 · STIEFEL LABORATORIES · OWNER
DemocraticDerived from contributionsWhere the contributions went · 10 per page
Showing 1–3 of 3 · largest absolute amount first
Senate campaign committee · WASHINGTON · DC · BROWN, SHERROD · U.S. Senate · OH · 00
DemocraticDerived from contributionsIndividual transactions · 10 per page
Dates below are the FEC-reported contribution dates, not filing or import dates. These are individual contributions grouped by the reported employer field, not contributions by a company.
Largest contribution amounts first. Select Date of contribution or Amount to reverse the order.
| Date of contribution ↕ | Amount ↓ | Reported contributor / location | Recipient / filing |
|---|---|---|---|
| 2023-11-24FEC filing ↗ | $289,100 | STIEFEL, LINDAKITTY HAWKNC27949OWNERSTIEFEL LABORATORIES | DCCCC00000935Primary (P)* OVER LIMIT TRANSFERRED TO ADDITIONAL ACCOUNTSFiling 1754923 · amended |
| 2023-11-30FEC filing ↗ | $123,900 | STIEFEL, LINDAKITTY HAWKNC27949OWNERSTIEFEL LABORATORIES | DCCCC00000935Recount 2023 (E2023)RECOUNT/LEGAL FUND CONTRIBUTIONFiling 1754923 · amended |
| 2023-11-30FEC filing ↗ | $123,900 | STIEFEL, LINDAKITTY HAWKNC27949OWNERSTIEFEL LABORATORIES | DCCCC00000935Primary 2023 (P2023)HEADQUARTERS/BUILDING FUND CONTRIBUTIONFiling 1754923 · amended |
| 2023-08-10FEC filing ↗ | $41,300 | STIEFEL, LINDAKITTY HAWKNC27949OWNERSTIEFEL LABORATORIES | DSCCC00042366Primary (P)Filing 1726111 |
| 2023-08-10FEC filing ↗ | $8,700 | STIEFEL, LINDAKITTY HAWKNC27949OWNERSTIEFEL LABORATORIES | DSCCC00042366Primary (P)Filing 1726111 |
| 2023-08-27FEC filing ↗ | $3,300 | STIEFEL, LINDAKITTY HAWKNC27949OWNERSTIEFEL LABORATORIES | FRIENDS OF SHERROD BROWNC00264697Primary 2024 (P2024)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1741367 · amended |
| 2023-08-27FEC filing ↗ | $3,300 | STIEFEL, LINDAKITTY HAWKNC27949OWNERSTIEFEL LABORATORIES | FRIENDS OF SHERROD BROWNC00264697General 2024 (G2024)* EARMARKED CONTRIBUTION: SEE BELOWFiling 1741367 · amended |
| 2023-11-30FEC filing ↗ | -$247,800 | STIEFEL, LINDAKITTY HAWKNC27949OWNERSTIEFEL LABORATORIES | DCCCC00000935Primary (P)* OVER LIMIT TRANSFERRED TO ADDITIONAL ACCOUNTSFiling 1754923 · amended |
Refunds remain negative. Memo-only rows are marked and are not additional money. Latest versions are selected within matching employer records; amendments that change the employer may affect the grouping.
Open full contribution table →Industry classification summary
Research indicates Stiefel Laboratories is a specialized pharmaceutical company focused on dermatology, which was acquired by GSK plc in 2009 and continues to operate as a specialist dermatology business unit within the group.
AI-generated classification based on saved sources
View source